Advertisement

Related Videos

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Opportunities to Optimize Cancer Policies Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Javid J. Moslehi, MD, on Cardiovascular and Thrombotic Considerations of Kinase Inhibitors: The Case of BTK Inhibitors

Advertisement

Advertisement




Dec
19
Today In Oncology
CD123-Targeting ADC Shows Activity in AML and BPDCN
Data Published on Incidence of Immune Checkpoint Inhibitor-Associated ITP
Gemcitabine Intravesical System Shows High Disease-Free Survival Rates in BCG-Unresponsive Papillary-Only NMIBC
Neoadjuvant SABR Improves Outcomes in Patients With RCC and IVC Tumor Thrombus
Lymphocyte Kinetics After CAR T Infusion Predict Survival Outcomes in Non-Hodgkin Lymphoma
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo